|
| Status |
Public on Aug 13, 2021 |
| Title |
Integrated Profiling Reveals Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
34479871 |
| |
| Submission date |
Mar 26, 2021 |
| Last update date |
Nov 12, 2021 |
| Contact name |
David Barras |
| E-mail(s) |
david.barras@chuv.ch
|
| Organization name |
Centre hospitalier universitaire vaudois
|
| Department |
Oncology
|
| Street address |
AGORA, Bugnon 25A
|
| City |
Lausanne |
| State/province |
Vaud |
| ZIP/Postal code |
1005 |
| Country |
Switzerland |
| |
|
| Platforms (4)
|
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
| GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
| GPL22790 |
Illumina MiniSeq (Homo sapiens) |
|
| Samples (52)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE165612 |
Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy |
| GSE166303 |
Metronomic Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy |
| GSE167455 |
Metronomic Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy |
|
| Relations |
| BioProject |
PRJNA717780 |
Less...
More...